Utilizing Artificial Intelligence to Manage COVID-19 Scientific Evidence Torrent with Risklick AI: A Critical Tool for Pharmacology and Therapy Development.

Journal: Pharmacology
PMID: 33910199

Abstract

INTRODUCTION: The SARS-CoV-2 pandemic has led to one of the most critical and boundless waves of publications in the history of modern science. The necessity to find and pursue relevant information and quantify its quality is broadly acknowledged. Modern information retrieval techniques combined with artificial intelligence (AI) appear as one of the key strategies for COVID-19 living evidence management. Nevertheless, most AI projects that retrieve COVID-19 literature still require manual tasks.

Authors

  • Quentin Haas
    Risklick AG, Spin-off University of Bern, Bern, Switzerland.
  • David Vicente Alvarez
    HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland.
  • Nikolay Borissov
    Risklick AG, Spin-off University of Bern, Bern, Switzerland.
  • Sohrab Ferdowsi
    HES-SO University of Applied Sciences and Arts Western Switzerland, Geneva, Switzerland.
  • Leonhard von Meyenn
    Risklick AG, Spin-off University of Bern, Bern, Switzerland.
  • Sven Trelle
    Clinical Trial Unit Bern, University of Bern, Bern, Switzerland.
  • Douglas Teodoro
    Department of Radiology and Medical Informatics, University of Geneva, Geneva, Switzerland.
  • Poorya Amini
    Risklick AG, Spin-off University of Bern, Bern, Switzerland.

Keywords

External Resources

Popular Topics
Recent Journals